Bradykinin, kallidin, and kallikrein : supplement
Author(s)
Bibliographic Information
Bradykinin, kallidin, and kallikrein : supplement
(Handbook of experimental pharmacology, v. 25,
Springer-Verlag, 1979
- us
- gw
Available at 27 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographies and indexes
Description and Table of Contents
Description
Volume XXV of the Handbook of Experimental Pharmacology series entitled "Bradykinin, Kallidin, and Kallikrein" was published in 1970. My aim in editing this volume of the series is not to replace, but to update the 1970 edition. During the decade preceding the publication of Vol. XXV, the existence of kinins and kallikreins gained acceptance, the protein components of the system were purified and characterized and the peptides were synthesized. Even after these accomplish- ments, interest in the subject has not abated, but has increased substantially. We have learned a great deal about the role that components of the kallikrein-kinin system play in other systems and about the immensely complex and intricate inter- actions in blood. Directly or indirectly, kallikrein and kinins affect the coagulation of blood, the activation of complement, and the generation of angiotensin. Kinins release or modulate the actions of other agents, including prostaglandins, histamine, and catecholamines. Inhibitors of kallikrein or kininase II are employed, for example, in extracorporeal circulation or in hypertension.
Kallikrein, kinins, and kininases, present in urine, were described first in 1925 and 1954, but have been ignored for decades. These substances are now studied extensively because of their possible role in blood pressure regulation. The evidence that kinins have a metabolic function is also increasing. The abundance of active components of the system in genital organs suggests a role in the fertilization process. The book is organized into chapters which bear upon these issues.
Table of Contents
I. The Plasma Kallikrein-Kinin System and Its Interrelationship With Other Components of Blood.- II. Kininogenases of Blood Cells (Alternate Kinin Generating Systems).- III. Enzymology of Glandular Kallikreins.- IV. Kallikrein Inhibitors.- V. Chemistry and Biologic Activity of Peptides Related to Bradykinin.- VI. Kinins in Nature.- VII. Bradykinin Receptors.- VIII. Bradykinin Radioimmunoassay.- IX. Kinins and the Peripheral and Central Nervous Systems.- X. Effects of Kinins on Organ Systems.- XI. Release of Vasoactive Substances by Kinins.- XII. Kininases.- XIII. Kallikrein in Exocrine Glands.- XIV. Renal and Urinary Kallikreins.- XV. Renal Kallikrein and Regulation of Blood Pressure in Man.- XVI. Kallikrein-Kinin System in Pathologic Conditions.- XVII. Bradykinin, Kallidin, and Kallikreins.- Author Index.
by "Nielsen BookData"